Scarella Chamy Anibal, Díaz-García César, Herraiz Sonia, Kliemchen Rodrigues Jhenifer
Centro de Reproducción Humana, Facultad Medicina, Universidad de Valparaíso, Valparaíso, Chile; Departamento de Obstetricia y Ginecología, Escuela de Medicina, Universidad de Valparaíso, Valparaíso, Chile. Address: Hontaneda 2664, Valparaíso, Región de Valparaíso, Chile, CP: 2341386. Email:
Grupo Acreditado de Investigación en Medicina Reproductiva, IIS La Fe, Valencia, España; Departamento de Pediatría, Obstetricia y Ginecología, Facultad de Medicina, Universidad de Valencia, Valencia, España; IVI-London, IVI-RMA Global, Londres, Reino Unido.
Medwave. 2017 Nov 16;17(9):e7090. doi: 10.5867/medwave.2017.09.7090.
In recent years, medical advances have substantially improved survival of cancer patients, generating growing concern about the quality of life of the survivors. Increased attention has been paid to reproductive problems after oncological treatments. International guidelines on fertility preservation in cancer patients require that healthcare teams discuss, as early as possible, the impact of cancer treatments on fertility and encourage access to fertility preservation techniques. The development of these techniques in women is a recent effort and many patients and health care providers are not familiar with their rapid expansion. This article discusses indications, results, and risks of the different options currently available.
近年来,医学进步显著提高了癌症患者的生存率,这使得人们越来越关注癌症幸存者的生活质量。肿瘤治疗后的生殖问题受到了更多关注。国际癌症患者生育力保存指南要求医疗团队尽早讨论癌症治疗对生育力的影响,并鼓励患者采用生育力保存技术。女性生育力保存技术是最近才发展起来的,许多患者和医疗服务提供者对其迅速发展并不熟悉。本文讨论了目前可用的不同选择的适应症、效果和风险。